ArticleImaging neuroscience (Cambridge, Mass.)
Meditation and neurofeedback: A systematic scoping review, synthesis, and future directions.
Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain criticality and advanced meditation "cessation" events: An intensively sampled electroencephalography case study.IBRO neuroscience reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofeedback (NF) has been proposed as a tool to support and expand access to meditation practice. Despite growing interest, no comprehensive review has examined neurofeedback for meditation-based interventions (NF-MED) across the full spectrum of practices. Here, we conducted a scoping systematic review according to PRISMA guidelines, mapping the NF-MED field across both clinical and non-clinical contexts, with three aims: (1) assess the current state of NF-MED studies, (2) evaluate how NF-MED meditative constructs and whether neural modulation shows evidence of transfer to behavioral or phenomenological outcomes, and (3) provide methodological recommendations for future work. Our analysis shows that the field is dominated by proof-of-concept studies and marked by substantial heterogeneity in design, implementation, and outcome measures, which hampers the assessment of efficacy and applicability of NF-MED. While NF-MED has been shown to consistently modulate neural activity, evidence for corresponding improvements in behavior, phenomenology, or transferable meditative skills remains limited. Additional research is thus essential for determining whether NF-MED can help practitioners overcome common meditative barriers, such as anxiety and self-doubt, and whether NF-MED can accelerate meditative development across the training spectrum from novice to advanced meditators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.